Skip to main content
Premium Trial:

Request an Annual Quote

EU Funds Development of Gene Regulation Software Suite

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CLC Bio said today that it is leading a consortium funded by the European Union to develop a software suite that will enable gene regulation analysis of a large number of genomes.

CLC Bio, Decode Genetics, Biobase, the University of Oxford, Hungary’s Alfred Renyi Institute of Mathematics, and Russia’s BioRainbow will use €1.6 million ($2.1 million) in EU funding to support the Comparative Genomics and Next Generation Sequencing, or COGANGS, project.

The COGANGS partners plan to develop a software suite that will enable the analysis of up to one thousand genomes at the same time.

“We will apply both the initial prototype and the final software package for the analysis of regions that have been identified to have strong disease associations in the human genome,” Gisli Masson, Decode’s director of bioinformatics, said in a statement.

Masson explained that the software suite could enable scientists to “unlock a lot of information in the vast collection of human DNA samples we already have, once this project enables us to do large-scale comparative genomics analyses.”

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.